secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sonendo, Inc. (SONX)
CIK:        0001407973
Form:       8-K
Filed at:   2024-10-10T23:59:59+00:00
Accession:  0000950170-24-113952
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sonendo prelim Q3 rev $7.9-$8.0M, raises FY2024 guidance; stalking horse bid for Biolase assets
--------------------------------------------------------------------------------

- Total revenue expected $7.9-$8.0M; console approx $1.8M, procedural instruments approx $5.1M.
- Cash, cash equivalents and short-term investments approx $17.3M at Sept 30, 2024.
- Full-year 2024 revenue guidance raised to $31.5-$32.5M from prior $31.0-$32.0M.
- Double-digit console backlog for third straight quarter.
- Positioned as stalking horse bidder to acquire certain assets of Biolase in Chapter 11 bankruptcy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1407973/000095017024113952/0000950170-24-113952-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1407973/000095017024113952/sonx-20241010.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-113952

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer